The AACE has updated its guidance on obesity and adiposity-based chronic disease to reflect a focus on improving overall ...

In Malawi's public hospitals, a quiet but devastating crisis is unfolding. Patients are increasingly being forced to buy medicines that are supposed to be free, as chronic drug shortages continue to ...

MoneyShow presents top investment ideas for 2026 from leading advisors. Part 4 includes Eli Lilly, Enterprise Products ...

REZENOPY™ received approval from the U.S. Food and Drug Administration (the "FDA”) on April 19, 2024. The newly issued patent is eligible for listing in the FDA’s Orange Book and, if listed, may ...

Good enough, the answer is right here before us as he is none other than Dr. Lucky Orimisan Aiyedatiwa (born 12 January 1965) ...

Specialty pharmaceuticals are typically high-cost therapies used to treat chronic, complex, or rare diseases. These products ...

MARANG: A lawyer appeared at a Magistrate's Court here Thursday (Jan 8) to face three charges of aiding and abetting drug distribution and possession last month. Che Muhammad Amir Syafiq Che Musa, 33, ...

The growing popularity of obesity drugs is expected to spur Indian pharma companies to sign licensing partnerships and distribution deals as they eye the lucrative segment. Indian companies started ...

Two studies led by an opioid treatment program run by the University at Buffalo and UBMD Emergency Medicine have found that ...

Company Transitions from Infrastructure Buildout to Active Market Execution as Expanded 510(k) Review Enters Final ...

Throughout 2025, Congress introduced several bills related to the pharmacy benefit management (PBM) industry. As with the 118th Congress in 2024 ...

MINNEAPOLIS, Dec. 26, 2025 /PRNewswire/ -- Gold Star Distribution, Inc. (Gold Star or "the Company") is recalling all FDA regulated products listed in this press release due to the presence of rodent ...